Stephen Humphreys from Huntswood discusses his latest article of the state of the market in consulting to pharmaceutical companies. The key point is that decreasing drug pipelines are leading to an improvement in research and development, more strategic marketing and significant cost-reduction, primarily through outsourcing. Paul Attridge, head of life sciences at CSC and John Rountree, Co-Founder at NovaSecta, feature in the article.
Link to this comment:
All Comments (0)